Neuroprotective Effects of a Cholecystokinin Analogue in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Parkinson’s Disease Mouse Model

Overview of attention for article published in Frontiers in Neuroscience, March 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

blogs: 1 blog

twitter: 4 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 9 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 10,873 followers.

https://t.co/su5gUpRdaW

04 Apr 2022

Reply Repost Favourite

Analogue of Cholecystokinin promotes dopamine neuron survival (via activation of the cAMP/PKA/CREB pathway) in a MPTP mouse model of #Parkinsons; Decreased glia activation & neuroinflammation, plus improved autophagy dysfunction; Liraglutide = comparit

04 Apr 2022

Reply Repost Favourite

New article: Neuroprotective Effects of a Cholecystokinin Analogue in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Parkinson's Disease Mouse Model https://t.co/SLUowHONgC #parkinsons #neurology https://t.co/m4rCK2zD2Q

04 Apr 2022

Reply Repost Favourite

Neuroprotective Effects of a Cholecystokinin Analogue in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Parkinson’s Disease Mouse Model https://t.co/fi8PgXiaLm

15 Mar 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.